Navigation Links
BioMarin Announces First Quarter 2011 Financial Results
Date:4/28/2011

linical Programs

  • BMN-111 for Achondroplasia: BioMarin expects to initiate a Phase I trial by the first quarter of 2012.  BMN-111 is an analog of C-type Natriuretic Peptide (CNP), a small cyclic peptide that is a positive regulator of bone growth, for achondroplasia, the most common form of dwarfism.  There are approximately between 18,000 and 24,000 patients in the U.S. and Europe, 25 percent of which is the estimated addressable market.
  • Other early stage programs: BioMarin is working on multiple early development opportunities.

  • Non-GAAP Financial Information and ReconciliationThe above results for the three months ended March 31, 2011 and March 31, 2010 and financial guidance for the year ending December 31, 2011 are presented both as determined in accordance with GAAP and on a non-GAAP basis. As used in this release, non-GAAP income is based on GAAP Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) adjusted to exclude non-cash stock compensation expense, contingent consideration expense and certain nonrecurring material items (adjusted EBITDA).  

    The following tables detail the reconciliation of non-GAAP to GAAP financial metrics:

    Reconciliation of GAAP Net Income (Loss) to Non-GAAP Adjusted EBITDA(in millions)(unaudited) Three Months EndedMarch 31, Year Ending December 31, 2011 NOTES20112010GuidanceGAAP Net Income (Loss)$
    (4.4)$
    .2$(52) - $(42)Interest expense, net1.41.26Income tax expense4.80.615Depreciation4.73.424Amortization0.90.14EBITDA (Loss)7.46.5(3) - 7Stock-based compensation10.48.543Gain on sale of equity investments-(0.9)-Contingent consideration

    (1)(0.5)0.711Adjusted EBITDA$
    7.3$
    4.8$51 - $61(1)  Represents the changes in the fair value of contingent acquisition consideration payable for the period.BioMarin believes that this non-GAAP information is useful to investors, taken in conjunction with BioMarin's GAAP information bec
    '/>"/>

    SOURCE BioMarin Pharmaceutical Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
    2. BioMarin Announces FDA Approval for Kuvan
    3. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
    4. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
    5. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
    6. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
    7. BioMarin Acquires Huxley Pharmaceuticals, Inc.
    8. BioMarin to Present at the Oppenheimer Healthcare Conference
    9. BioMarin Announces Third Quarter 2009 Financial Results
    10. BioMarin to Acquire LEAD Therapeutics
    11. BioMarin to Present at the Credit Suisse Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/22/2015)... , May 22, 2015 ... phase clinical research unit with a worldwide reputation ... for its frequent publications in peer reviewed medical ... European stakeholders and regulators in discussions about rules ...      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , ...
    (Date:5/22/2015)... -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD ) ("Nepstar" ... China based on the number ... Mr. Fuxiang Zhang as the Company,s Chief ... Rebecca Yingnan Zhang has been appointed as Chief ... immediately. Meanwhile, Ms. Zhang resigned from the position as ...
    (Date:5/21/2015)... 2015  When Ryan Rendino first felt ... his neck, he figured it was a ... off from weight lifting. But ... A series of doctor appointments ... Michel Kliot, MD , a ...
    Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4
    ... Comparing Gene Expression in Female and Male Patients Presented at ... Inc. (Nasdaq: GHDX ) today announced results from ... Onco type DX(R) breast cancer test in a large ... to guide treatment with chemotherapy. The results, which will be ...
    ... Evidence of Biological Activity in 9 of 12 Patients; ... Medical CentersSAN DIEGO, May 28 Celladon Corporation presented ... Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID), ... symposium at the 12th Annual American Society of Gene ...
    Cached Medicine Technology:Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 2Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 3Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 4Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 5Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting 2Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting 3Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting 4
    (Date:5/22/2015)... Carnegie Science Center and ... partnership to develop BodyTech, a dynamic, three-pronged health and ... a new exhibit at the Science Center called BodyWorks, ... new traveling science show, Anatomy Adventure, which will hit ... Designed to explore a wide range of topics surrounding ...
    (Date:5/22/2015)... California (PRWEB) May 22, 2015 Coco Libre, ... set a RecordSetter.com World Record at the 104th running of ... coconut water ice luge served 315 people in one hour—one ... to Breakers race is so true to the heart of ... felt bringing an ice luge to the finish line only ...
    (Date:5/22/2015)... 22, 2015 Medivo, Inc., a leader in ... and Genotype Results in ‘Baby Boomers’ Screened for HCV Following ... Lab Test Database” at Digestive Disease Week, May 16-19, 2015. ... and Analytics team members Carol Smyth, MB; Jason Bhan, MD; ... MSI, along with Nancy Reau, MD from the University of ...
    (Date:5/22/2015)... Ticket Down is a reputable source for authentic ... Conference Finals Tickets . All seating for the 2015 ... ticket listing. , For the first time in some ... the Eastern Conference. One of the original franchises in the ... downs over the years, but the excitement level for this ...
    (Date:5/22/2015)... A new program for the "In America" television series ... Therapy. , James Earl Jones will host the ... therapy and discusses how the exercises can decrease pain ... ailments and injuries. Physical therapists work with their ... daily activities such as house cleaning and shopping, work ...
    Breaking Medicine News(10 mins):Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4Health News:Coco Libre Ice Luge Sets New World Record at Bay to Breakers 2Health News:Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 3
    ... chimpanzees is so much alike the code of humans, almost ... us. And yet, // there are glaring differences, despite the ... was not a different set of genes that caused the ... utilized. According to a latest theory on evolution, even small ...
    ... research has suggested that Women with disproportionate or uneven breasts ... mammography is designed to record any alterations or changes in ... University of Liverpool team conducted a study where mammograms of ... number of mammograms from healthy women. It was observed ...
    ... Von Eschenbach, nominated to run the U.S. Food and ... to political pressure while scientific decisions were being made//. ... effectiveness of medical endeavors, the appropriateness should also be ... administrator of the FDA and Director of National Cancer ...
    ... millions of people. Scientists at the University of Dundee have ... and asthma. ,This gene produces the protein filaggrin. ... the skin. It prevents bacteria and viruses from colonizing the ... skin from drying. Reduction or absence of the protein leads ...
    ... new light on the mechanism of nerve cell growth ... myosin-II, according to an //article in the March issue ... attempt to recover after damage, they extend growth cones, ... cones use the information they gather to direct advance ...
    ... check the mushrooming growth of beauty clinics in the ... ,"A Beauty Parlour Act will be sent to ... Sharma, chairperson of the rules and regulation committee of ... him, the decision to enact the act was taken ...
    Cached Medicine News:Health News:FDA Nominee Says That He Is Not Influenced By Politics 2Health News:Gene That Causes Dry Skin, Identified 2Health News:A New Focus For The Mechanism Of Nerve Growth 2
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    Medicine Products: